CorMedix (CRMD) Free Cash Flow (QoQ) (2010 - 2025)
CorMedix (CRMD) Free Cash Flow (QoQ) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - |
| 4 | BeOne Medicines | 469.79 Bn | 465.00 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.95 Bn | 115.70 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.30 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.62 Bn | 62.62 Bn | - |
| 8 | Argenx Se | 56.18 Bn | 50.99 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | CorMedix | 5.06 Mn | -150.14 Mn | 107.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 205.56% |
| Sep 30, 2025 | 1.28% |
| Jun 30, 2025 | 51.92% |
| Mar 31, 2025 | 450.69% |
| Dec 31, 2024 | 58.82% |
| Sep 30, 2024 | 2.95% |
| Jun 30, 2024 | 18.98% |
| Mar 31, 2024 | -57.33% |
| Dec 31, 2023 | -26.80% |
| Sep 30, 2023 | -1.50% |
| Jun 30, 2023 | 17.58% |
| Mar 31, 2023 | -65.65% |
| Dec 31, 2022 | -3.49% |
| Sep 30, 2022 | -10.96% |
| Jun 30, 2022 | 18.92% |
| Mar 31, 2022 | -3.86% |
| Dec 31, 2021 | -3.45% |
| Sep 30, 2021 | -102.81% |
| Jun 30, 2021 | 53.80% |
| Mar 31, 2021 | -11.54% |